GSIT:NASDAQGSI Technology, Inc. Analysis
Data as of 2026-06-17 - not real-time
$7.55
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: The 20‑day SMA (9.06) sits above the 50‑day (8.26) and 200‑day (7.01) averages, confirming a bullish trend, yet the MACD is bearish (line below signal, negative histogram) and RSI at 41.6 suggests momentum is fading. Volume is on a downtrend, and the stock’s 30‑day volatility of 146% combined with a computed beta of 4.68 indicates extreme price swings. The market sentiment index reads Extreme Greed (92.13), but the max drawdown of –63% underscores the risk of further declines.
Fundamental outlook: Revenue grew 7.4% YoY to $25.1 M with a solid gross margin of 54.5%, yet operating margin is –82% and the company posts negative cash flow and free cash flow. Debt‑to‑equity is high at 10.3, though cash balances ($67.2 M) comfortably exceed debt. No dividend is paid, and the PE is negative, while price‑to‑book (3.38) and price‑to‑sales (11.5) are elevated relative to the weak earnings profile.
Fundamental outlook: Revenue grew 7.4% YoY to $25.1 M with a solid gross margin of 54.5%, yet operating margin is –82% and the company posts negative cash flow and free cash flow. Debt‑to‑equity is high at 10.3, though cash balances ($67.2 M) comfortably exceed debt. No dividend is paid, and the PE is negative, while price‑to‑book (3.38) and price‑to‑sales (11.5) are elevated relative to the weak earnings profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD and falling volume
- High volatility and beta
- Negative earnings and cash flow
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Revenue growth and improving gross margin
- Strong cash cushion relative to debt
- Potential upside from niche defense and aerospace markets
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Fundamental profitability challenges remain
- Cyclical semiconductor sector risk
- Sustained high valuation multiples without earnings recovery
Key Metrics & Analysis
Financial Health
Revenue Growth7.40%
Profit Margin-52.73%
P/E Ratio-13.7
ROE-24.09%
ROA-15.46%
Debt/Equity10.36
P/B Ratio3.4
Op. Cash Flow$-15923000
Free Cash Flow$-7656125
Industry P/E37.2
Technical Analysis
TrendBullish
RSI41.6
Support$7.08
Resistance$11.63
MA 20$9.06
MA 50$8.26
MA 200$7.01
MACDBearish
VolumeDecreasing
Fear & Greed Index92.13
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta4.68
Volatility146.01%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.